AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| RNE | Ann: Final share buy-back notice - Appendix 3F | 23/04/18 | 0 | 115 | |||
|
|||||||
| RNE | Ann: Head of Terms to fund $100m bioenergy business development | 20/04/18 | 35 | 4.9K | |||
|
|||||||
| RNE | Ann: Trading Halt | 16/04/18 | 7 | 1.3K | |||
|
|||||||
| RNE | Ann: Goulburn Bioenergy Project commences commercial operation | 15/04/18 | 37 | 5.3K | |||
|
|||||||
| RNE | Ann: Lapse of equity incentives of former CEO | 05/04/18 | 2 | 404 | |||
|
|||||||
| RNE | Ann: ReNu Energy appoints acting CEO and new COO | 05/04/18 | 0 | 163 | |||
|
|||||||
| RNE | Ann: Employee share scheme buy-back - Appendix 3C | 05/04/18 | 0 | 80 | |||
|
|||||||
| RNE | Ann: Final Director's Interest Notice | 05/04/18 | 0 | 70 | |||
|
|||||||
See All Discussions
ASX News